Is HeartSciences Inc. (HSCS) Halal?

NASDAQ Healthcare United States $7M
✗ NOT HALAL
Confidence: 90/100
HeartSciences Inc. (HSCS) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 35.6% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. HeartSciences Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from April 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 35.6%
/ 30%
13.1%
/ 30%
0.1%
/ 30%
2018.28%
/ 5%
✗ NOT HALAL
DJIM 35.6%
/ 33%
13.1%
/ 33%
0.1%
/ 33%
2018.28%
/ 5%
✗ NOT HALAL
MSCI 70.7%
/ 33%
26.0%
/ 33%
0.1%
/ 33%
2018.28%
/ 5%
✗ NOT HALAL
S&P 35.6%
/ 33%
13.1%
/ 33%
0.1%
/ 33%
2018.28%
/ 5%
✗ NOT HALAL
FTSE 70.7%
/ 33%
26.0%
/ 33%
0.1%
/ 50%
2018.28%
/ 5%
✗ NOT HALAL

Financial Highlights

EPS
$-4.49
P/B Ratio
2.7
EV/EBITDA
-1.0
EV: $8M
Revenue
$4,350
Beta
2.5
High volatility
Current Ratio
1.2

Profitability

Gross Margin 57.9%
Operating Margin -89939.6%
Net Margin 0.0%
Return on Equity (ROE) -382.3%
Return on Assets (ROA) -73.5%

Cash Flow & Balance Sheet

Operating Cash Flow-$7M
Free Cash Flow-$7M
Total Debt$3M
Debt-to-Equity145.8
Current Ratio1.2
Total Assets$4M

Price & Trading

Last Close$2.31
50-Day MA$2.89
200-Day MA$3.22
Avg Volume25K
Beta2.5
52-Week Range
$2.01
$6.47

About HeartSciences Inc. (HSCS)

CEO
Mr. Andrew Simpson
Employees
15
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$7M
Currency
USD

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is HeartSciences Inc. (HSCS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), HeartSciences Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is HeartSciences Inc.'s debt ratio?

HeartSciences Inc.'s debt ratio is 35.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 70.7%.

What are HeartSciences Inc.'s key financial metrics?

HeartSciences Inc. has a market capitalization of $7M, and revenue of $4,350. Return on equity stands at -382.3%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.